Skip to content

Peptide Glossary (A–Z)

A comprehensive reference of peptide science terminology used throughout the RPL Peptide Documentation Library.

A

Amino Acid — An organic compound containing an amino group (-NH₂) and a carboxyl group (-COOH). The 20 standard amino acids are the building blocks of peptides and proteins.

Amino Acid Analysis (AAA) — An analytical method for determining the amino acid composition of a peptide by complete acid hydrolysis (6 M HCl, 110°C, 24 h) followed by chromatographic separation and quantification. Used for identity confirmation and peptide content determination.

Amidation — A C-terminal modification where the carboxyl group is converted to a carboxamide (-CONH₂). Amidation improves metabolic stability and often enhances biological activity by mimicking natural peptide structures.

B

Batch (Lot) — A defined quantity of material produced in a single manufacturing cycle under consistent conditions. Each batch is assigned a unique identifier for traceability.

Bioassay — A method for determining the biological activity of a compound using living cells, tissues, or organisms. Common peptide bioassays include cAMP accumulation, calcium flux, and reporter gene assays.

C

C18 Column — A reversed-phase HPLC column with octadecyl (C₁₈) bonded silica stationary phase. The most widely used column type for peptide analysis and purification.

Certificate of Analysis (COA) — An official quality document listing batch-specific analytical results, including test parameters, specifications, measured values, and conformance statements.

Counterion — An ion of opposite charge that associates with the charged peptide molecule. The most common counterion in synthetic peptides is trifluoroacetate (TFA⁻) from HPLC purification. Counterion content affects the total mass and may impact bioassay results.

D

Deletion Sequence — An impurity where one or more amino acids are missing from the target sequence due to incomplete coupling during solid-phase peptide synthesis. Detection by HPLC or LC-MS.

DMSO (Dimethyl Sulfoxide) — A polar aprotic solvent with high solvation capacity for hydrophobic compounds. In cell-based assays, final DMSO concentration must be ≤0.1% to avoid cytotoxicity.

E

EC₅₀ (Half-Maximal Effective Concentration) — The concentration of a compound that produces 50% of its maximal effect in a biological assay. A measure of potency.

Endotoxin — Lipopolysaccharide (LPS) components from Gram-negative bacterial cell walls. Measured by the Limulus Amebocyte Lysate (LAL) assay to ensure product safety for cell-based and in vivo studies.

ESI (Electrospray Ionization) — A soft ionization technique for mass spectrometry that produces multiply charged ions from solution-phase samples. Used for molecular weight confirmation of peptides.

F

Fmoc Chemistry — The most common strategy for solid-phase peptide synthesis, using 9-fluorenylmethoxycarbonyl (Fmoc) as the temporary N-terminal protecting group. Fmoc is removed by base (piperidine) treatment.

Freeze-Thaw Cycle — The process of freezing and thawing a sample. Repeated cycles can cause peptide degradation and aggregation due to cryoconcentration effects.

G

GHS (Globally Harmonized System) — An international system for classifying and labeling chemicals based on their health, physical, and environmental hazards.

GPCR (G Protein-Coupled Receptor) — A large family of cell surface receptors that mediate cellular responses to diverse stimuli, including peptide hormones and neurotransmitters. Many research peptides target GPCRs.

H

HPLC (High-Performance Liquid Chromatography) — A chromatographic technique for separating, identifying, and quantifying components in a mixture. The primary analytical method for peptide purity determination.

Hydrophobicity — The tendency of a molecule or region to repel water. In peptides, hydrophobic amino acids (Leu, Ile, Val, Phe, Trp) influence solubility, aggregation propensity, and membrane interactions.

I

IC₅₀ (Half-Maximal Inhibitory Concentration) — The concentration of a compound required to inhibit a biological process by 50%.

Impurity Profile — The complete characterization of all substances other than the target peptide in a sample, including deletion sequences, truncations, oxidation products, and process-related impurities.

Incretin — A gut hormone that potentiates glucose-stimulated insulin secretion. GIP (Glucose-dependent Insulinotropic Polypeptide) and GLP-1 (Glucagon-Like Peptide-1) are the primary incretin hormones.

K

Karl Fischer Titration — A coulometric or volumetric titration method for determining water content. Essential for characterizing lyophilized peptides (target: < 5% water).

L

LC-MS (Liquid Chromatography-Mass Spectrometry) — A hyphenated analytical technique combining HPLC separation with mass spectrometric detection. Used for identity confirmation, molecular weight determination, and impurity identification.

Lyophilization (Freeze-Drying) — A drying process where frozen material is placed under vacuum to sublime water directly from solid to vapor. Produces a stable, porous peptide cake with extended shelf life.

M

Mass Accuracy — The difference between measured and calculated molecular mass, expressed in daltons (Da) or parts per million (ppm). Typical mass accuracy for peptide LC-MS: < 5 ppm.

MOQ (Minimum Order Quantity) — The smallest quantity of a product that RPL Peptide will supply in a single order. Standard MOQ: 10 mg.

N

Ninhydrin Test (Kaiser Test) — A colorimetric test for detecting free primary amines. Used in SPPS to monitor coupling efficiency. Blue color indicates incomplete coupling.

O

Oxidation — A degradation pathway where reactive oxygen species modify amino acid side chains. Methionine (Met), cysteine (Cys), and tryptophan (Trp) are most susceptible.

P

Peptide Bond — A covalent amide bond (-CO-NH-) formed between the carboxyl group of one amino acid and the amino group of another. The fundamental linkage in peptides and proteins.

Peptide Content — The percentage of the desired peptide species relative to the total mass of the lyophilized product. Determined by HPLC or amino acid analysis.

pI (Isoelectric Point) — The pH at which a peptide has no net electrical charge. Solubility is minimal at the pI.

Q

Quality by Design (QbD) — A systematic approach to pharmaceutical development that begins with predefined objectives and emphasizes product and process understanding and process control.

R

Reconstitution — The process of dissolving a lyophilized peptide in a suitable solvent for experimental use. Proper technique is critical for maintaining peptide integrity.

RSD (Relative Standard Deviation) — A measure of precision calculated as (standard deviation / mean) × 100%. For HPLC injections: ≤ 2%.

S

SPPS (Solid-Phase Peptide Synthesis) — A method for chemical synthesis of peptides where the growing peptide chain is anchored to an insoluble resin support, allowing efficient washing and purification between coupling steps.

Sequence (Amino Acid Sequence) — The linear order of amino acids in a peptide, typically written from N-terminus (left) to C-terminus (right) using one-letter or three-letter codes.

T

TFA (Trifluoroacetic Acid) — A strong acid used as an ion-pairing agent in HPLC mobile phases and as a residual counterion in lyophilized peptide products. TFA content typically accounts for 5–15% of total product mass.

Truncation — An impurity resulting from incomplete chain assembly during synthesis, producing shorter peptide fragments lacking C-terminal residues.

U

UPLC (Ultra-Performance Liquid Chromatography) — A high-resolution variant of HPLC using sub-2 µm particle columns, operating at higher pressures (up to 15,000 psi) for faster, more efficient separations.

V

Validation (Method) — The documented process of demonstrating that an analytical method is suitable for its intended purpose, as defined by ICH Q2(R1) guidelines.

W

Water Content — The percentage of water in a lyophilized peptide product, measured by Karl Fischer titration. RPL Peptide specification: ≤ 5%.

Z

Z' Factor — A dimensionless statistical measure of assay quality in high-throughput screening. Z' = 1 − [3(SD₊ + SD₋) / |Mean₊ − Mean₋|]. Values: > 0.5 acceptable, > 0.7 excellent.